Jardiance 30 Film 10 ml

Jardiance 30 Film 10 ml

Description:

Jardiance 10 mg film-coated tablets (Jardiance 30 Film 10 ml) is a prescription oral antidiabetic medicine containing empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor. It is used as part of a comprehensive diabetes care plan, along with diet and exercise, to help lower blood sugar levels in adults with type 2 diabetes mellitus. Jardiance also helps reduce the risk of cardiovascular death in adults with type 2 diabetes who have established cardiovascular disease. This product is classified as a medicine under diabetes care and health prevention.

Indications:

• Management of blood glucose levels in adults with type 2 diabetes mellitus, as an adjunct to diet and exercise.
• Can be used alone (monotherapy) or in combination with other antidiabetic medicines such as metformin, insulin, or other oral agents, as prescribed by a physician.
• Reduction of the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.
• Helps improve glycemic control by increasing urinary glucose excretion, thereby lowering elevated blood sugar levels and associated symptoms such as excessive thirst and frequent urination.
• Not indicated for the treatment of type 1 diabetes mellitus.
• Not indicated for the treatment of diabetic ketoacidosis.

Active Ingredients / Key Components:

• Empagliflozin – 10 mg per film-coated tablet.
• Excipients (inactive ingredients) such as tablet core and film-coating components are present, but a full excipient list and their concentrations , please check the product leaflet or the manufacturer’s official website.

Dosage & Administration / How to Use:

• Usual adult dose: 10 mg empagliflozin orally once daily, as prescribed by the treating physician.
• The dose may be increased to 25 mg once daily if additional glycemic control is required and if tolerated, according to physician judgment and local guidelines.
• Take the tablet once a day, at the same time each day, with or without food. Swallow the tablet whole with water; do not crush or chew unless otherwise directed by your doctor.
• Continue to follow a diabetes-appropriate diet and exercise plan as recommended by your healthcare provider while taking Jardiance.
• If a dose is missed, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose and resume the regular schedule. Do not take a double dose to make up for a missed one.
• Use in patients with kidney impairment requires careful assessment. Jardiance must not be used in patients with severe kidney problems or those on dialysis.
• Not recommended for children and adolescents under 18 years of age.
• Always use under medical supervision and do not change the dose or stop the medication without consulting your doctor.

Clinical Benefits:

• Helps lower elevated blood sugar levels in adults with type 2 diabetes by increasing urinary glucose excretion via SGLT2 inhibition in the kidneys.
• Contributes to a reduction in the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, when used as part of standard care.
• May support modest weight reduction and a decrease in blood pressure in some patients as a result of its mechanism of action (increased glucose and osmotic diuresis), as observed in clinical studies.
• Offers once-daily oral dosing, helping improve treatment adherence as part of long-term diabetes management.

Warnings & Contraindications:

• Do not use Jardiance if you are allergic (hypersensitive) to empagliflozin or any of the excipients in the product.
• Contraindicated in patients with type 1 diabetes mellitus.
• Contraindicated in patients with diabetic ketoacidosis (DKA) or a history of DKA; Jardiance is not suitable for the treatment of DKA.
• Do not take Jardiance if you have severe kidney problems, significantly reduced kidney function, or are on dialysis.
• Not recommended for children and adolescents under 18 years of age due to insufficient safety and efficacy data.
• Jardiance should not be used during pregnancy or breast-feeding. If you become pregnant or are planning to become pregnant, inform your doctor immediately.
• Use with caution in patients with a history of recurrent urinary tract infections, genital infections, low blood pressure, dehydration, or elderly patients, as the risk of volume depletion and infections may be increased.
• Inform your doctor if you have liver disease, kidney disease, cardiovascular disease, or are taking diuretics, blood pressure medicines, or other antidiabetic drugs, as dose adjustments and monitoring may be required.
• There is a risk of ketoacidosis, even with normal or moderately increased blood glucose levels; seek medical attention if you develop symptoms such as nausea, vomiting, abdominal pain, excessive tiredness, or difficulty breathing.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as kidney disease, liver disease, cardiovascular disease, or hypotension.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include increased urination, urinary tract infections, genital fungal infections (such as yeast infections), thirst, and mild dehydration.
• Other possible side effects can include low blood pressure (hypotension), especially in patients taking diuretics or those with impaired kidney function, and increases in blood lipids in some patients.
• Serious but less common side effects may include diabetic ketoacidosis (DKA), severe urinary tract infections, Fournier’s gangrene (necrotizing fasciitis of the perineum), and severe allergic reactions.
• Stop using the medicine and seek immediate medical attention if you experience symptoms of severe allergic reaction (rash, itching, swelling of the face, lips, tongue, or throat, difficulty breathing), signs of ketoacidosis (nausea, vomiting, abdominal pain, difficulty breathing, confusion, unusual fatigue), or signs of severe infection.
• Report any unusual or persistent side effects to your doctor or pharmacist for further evaluation.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep the original blister pack tightly closed until use to protect the tablets from moisture. Do not store above the temperature specified on the package (exact storage temperature is not available in the provided information; follow the pack insert). Keep out of reach of children.

Specifications:

• Form: Film-coated tablets for oral use.
• Strength: 10 mg empagliflozin per tablet.
• Pack size: 30 film-coated tablets (Jardiance 10 mg 30 f.c. tabs).
• Intended use: Prescription antidiabetic medicine for adults with type 2 diabetes mellitus.
• Concentration details of excipients and full formulation , please check the product leaflet or the manufacturer’s official website.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.